Press release
Compounding Pharmacy Market to Reach $19.41 Billion by 2030 Driven by Drug Shortages and Personalized Medicine Demand
According to MarketsandMarkets Trademark , the global compounding pharmacy market [https://www.marketsandmarkets.com/Market-Reports/compounding-pharmacy-market-57885999.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] is projected to grow from USD 14.72 billion in 2025 to USD 19.41 billion by 2030, at a CAGR of 5.7%. Persistent drug shortages across major markets and stricter enforcement of USP standards are accelerating demand for high-quality, customized pharmaceutical solutions. As healthcare shifts toward personalization, how critical are compounding pharmacies in addressing unmet patient needs?
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=57885999 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=57885999&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Browse
* 480 Market Data Tables
* 60 Figures
* 350 Pages and in-depth TOC on " Compounding Pharmacy Market - Global Forecast to 2030 ".
What is driving the demand for compounded medications?
Increasing incidences of drug shortages in North America and Europe are compelling healthcare providers to rely on compounding pharmacies for tailored alternatives. Additionally, the growing emphasis on patient-specific therapies-particularly for pediatric, geriatric, and chronic disease populations-is strengthening the role of compounding in modern healthcare delivery.
Why do oral formulations dominate the product landscape?
Oral drugs accounted for the largest market share in 2024, owing to their versatility and widespread use across multiple therapeutic areas. Customized oral formulations-such as capsules, tablets, and suspensions-allow precise dosage adjustments, taste masking, and improved bioavailability. These advantages enhance patient adherence, particularly among populations with swallowing difficulties or requiring individualized dosing.
Which therapeutic segment is emerging as a key growth driver?
Hormone replacement therapy (HRT) is expected to register the fastest growth during the forecast period. The increasing prevalence of hormonal imbalances and age-related conditions is driving demand for personalized HRT solutions. Compounded therapies offer flexibility in hormone type, dosage, and delivery method, improving treatment efficacy and minimizing side effects. Advances in bioidentical hormones and transdermal delivery systems are further supporting this segment's rapid expansion.
How is regulatory compliance shaping the market? Strict adherence to USP standards and regulatory oversight is enhancing the safety, quality, and reliability of compounded medications. This is strengthening trust among healthcare providers and patients, while also encouraging the adoption of advanced compounding technologies and sterile preparation systems.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=57885999 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=57885999&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Regional Insights:
Which regions are leading and where are the growth opportunities? North America held the largest market share in 2024, driven by established healthcare infrastructure and high awareness of personalized medicine. Meanwhile, Asia Pacific is emerging as the fastest-growing region, supported by increasing healthcare access, rising disposable incomes, and growing demand for customized therapies in countries such as China, India, Japan, and Australia.
Market Insights:
Key players in the compounding pharmacy market include Baxter (US), Empower Pharmacy (US), B. Braun (Germany), Fagron (Netherlands), QuVa Pharma (US), SCA Pharma (US), Nephron Pharmaceuticals (US), Leiters Health (US), and Pharmaxo (UK). These companies are focusing on expanding sterile compounding capabilities, enhancing regulatory compliance, and investing in advanced formulation technologies to strengthen their market position.
As the demand for personalized medicine and reliable drug supply continues to grow, stakeholders must leverage opportunities in compounding innovation and regulatory compliance. To access comprehensive market insights, competitive analysis, and growth strategies, explore the full report today.
Related Reports:
Pain Management Devices Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91418163&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2029
Topical Drug Delivery Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124871717&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2030
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=compounding-pharmacy-market-to-reach-1941-billion-by-2030-driven-by-drug-shortages-and-personalized-medicine-demand]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/compounding-pharmacy-market-57885999.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Compounding Pharmacy Market to Reach $19.41 Billion by 2030 Driven by Drug Shortages and Personalized Medicine Demand here
News-ID: 4488149 • Views: …
More Releases from ABNewswire
The Boulder Group Arranges Sale of a Net Leased Fast Pace Health Property in La …
The Boulder Group, a net leased investment brokerage firm, completed the sale of a single tenant net leased Fast Pace Health urgent care property located at 1320 W State Rd 2 in La Porte, Indiana for $2,965,000. The 3,726-square-foot building was constructed in 2023 specifically for Fast Pace Health and sits on a 0.93-acre parcel in La Porte, Indiana.
The Fast Pace Health property at 1320 W State Rd 2 in…
Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) Leading $5.21B Oral Thi …
The oral thin film drug delivery market is entering a high-growth phase, with industry forecasts projecting expansion from $3.30 billion in 2025 to $5.21 billion by 2030, representing a 9.56% CAGR. As demand accelerates for faster, more efficient drug delivery systems, companies positioned at the forefront of this innovation-such as Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF)-are increasingly drawing investor attention.
A Market Shift Toward Faster, Smarter Drug Delivery
The growth of…
Aerospace and Defense Telemetry Market size to Reach USD 3.12 Billion by 2031 Dr …
Mordor Intelligence has published a new report on the aerospace and defense telemetry market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Aerospace and Defense Telemetry Market Overview
According to Mordor Intelligence, the [https://www.mordorintelligence.com/industry-reports/aerospace-and-defense-telemetry-market?utm_source=abnewswire] is projected to grow from USD 2.08 billion in 2025 to USD 2.23 billion in 2026, and it is expected to reach USD 3.12 billion by 2031, reflecting steady expansion across the global aerospace and…
Kartoon Studios (NYSE American: TOON) Surges on Volume as Media Consolidation Ac …
Kartoon Studios (NYSE: TOON) is gaining significant investor attention as momentum builds across the media sector following reports that investors have approved a major transaction involving Warner Bros. Discovery (NASDAQ: WBD) and Paramount Skydance (NASDAQ: PSKY), intensifying consolidation across streaming and entertainment markets.
Against this backdrop, TOON has begun to stand out as a smaller-cap player positioned within the evolving content ecosystem. The stock has experienced a notable surge in trading…
More Releases for Pharma
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
